Mastering Corporate Turnarounds: Jeffrey S. Stein on Restructuring, Resilience, and Business Revival
With a distinguished background in economics and finance, Mr. Stein offers a unique perspective on the challenges and ...
With retail space in scarce supply, it has not been difficult to entice new tenants to small spaces like Medical Arts ...
A recent analysis by the Pharmaceutical Care Management Association estimates that Alabama’s proposed Senate Bill 99, (SB99), ...
Avoiding a second trial, a former pharmaceutical rep who prosecutors said generated more than $10 million in wrongful insurance reimbursements pleaded guilty Tuesday to perjury in U.S. District Court.
If Texas finds a way to regulate PBM interactions with self-insured employer health plans, that could lead to a wide range of ...
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
The company blamed for the death of a young Wisconsin man who died from an asthma attack after his medication price rose from ...
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim ...
Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results